[1]
Parimi, S., Tsang, E., Alexander, A., McKenzie, M., Bachand, F., Sunderland, K., Chi, K.N., Aparicio, M., Worsley, D. and Tyldesley, S. 2017. A population-based study of the use of radium 223 in metastatic castration-resistant prostate cancer: Factors associated with treatment completion. Canadian Urological Association Journal. 11, 10 (Oct. 2017), 350–5. DOI:https://doi.org/10.5489/cuaj.4415.